Bafna Pharma.

BAFNAPH26 Apr 2024

Pharmaceuticals

₹

+0.87 (+1.00%)

Lowest Today

Highest Today

Prev. Close

Today’s Open

52 Week High

52 Week Low

BUY

SELL

To Invest in Bafna Pharma.

Bafna Pharma.

Pharmaceuticals

BAFNAPH26 Apr 2024

₹

+0.87 (+1.00%)

OverviewFundamentals

Corporate action

Peer comparison

Income Sheet

Balance sheet

Cash flow

Share holding

About Us

Corporate Action

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

All

Dividends

Bonus

Splits

Others

Ex-Date	Type	Description	Record Date
21-May-2013	D	Bafna Pharmaceuticals Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 20, 2013, inter alia, has transacted the following : 1. Have recommended a final dividend of Rs. 0.60 per equity share (6%), subject to the approval of the shareholders at the ensuing Annual General Meeting of the Company.	19-Sep-2013
23-Apr-2024	BC	We hereby inform that Mr. Vishnu Vasudeva Kuppa has resigned from the position of Company Secretary & Compliance officer of the Company with effect from 23rd April, 2024	23-Apr-2024
02-Feb-2024	BC	BAFNA PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2024 inter alia to consider and approve A meeting of board of directors of t	12-Feb-2024
25-Dec-2023	BC	SRJR Lifesciences LLP	22-Dec-2023
30-Oct-2023	BC	BAFNA PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/11/2023 inter alia to consider and approve A meeting of Board of Directors of t	09-Nov-2023
14-Aug-2023	BC	AGM 22/09/2023 the 28th Annual General Meeting of the Members of the Company will be held on Friday, September 22, 2023, at 10:25 am IST, through Video Conferencing (VC)/ Other Audio-Visual Means	22-Sep-2023

No Rights has been declared by BAFNAPH

Book Closure

Record Date	Split Date	Purpose
23-Apr-2024	-	We hereby inform that Mr. Vishnu Vasudeva Kuppa has resigned from the position of Company Secretary & Compliance officer of the Company with effect from 23rd April, 2024
12-Feb-2024	-	BAFNA PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2024 inter alia to consider and approve A meeting of board of directors of t
22-Dec-2023	-	SRJR Lifesciences LLP
09-Nov-2023	-	BAFNA PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/11/2023 inter alia to consider and approve A meeting of Board of Directors of t
22-Sep-2023	-	AGM 22/09/2023 the 28th Annual General Meeting of the Members of the Company will be held on Friday, September 22, 2023, at 10:25 am IST, through Video Conferencing (VC)/ Other Audio-Visual Means

Peer Comparison

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Scrip Name	Price	Daily Change	M.Cap (Cr)	1 Year Returns %	P/E (TTM)	PB Ratio
Bafna Pharmaceuticals Ltd ₹87.81(+0.87/1.00%)	87.81	+0.87	207.73	3.22	18.45	2.52
Astrazeneca Pharma India Ltd ₹5,415.40(+81.55/1.53%)	5,415.40	+81.55	13,538.50	71.09	84.88	20.67
Bliss GVS Pharma Ltd ₹122.60(+5.85/5.01%)	122.60	+5.85	1,283.51	60.79	18.80	1.31
Cipla Ltd ₹1,409.40(+4.00/0.28%)	1,409.40	+4.00	113,794.25	54.54	34.60	4.40
Abbott India Ltd ₹25,864.85(+201.35/0.78%)	25,864.85	+201.35	54,962.81	15.87	47.98	17.68
Amrutanjan Health Care Ltd ₹680.85(-8.80/-1.28%)	680.85	-8.80	1,968.38	13.21	44.73	7.51

Income Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Gross Sales	28.44	40.68	41.95	42.24	34.22	21.96
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	28.44	40.68	41.95	42.24	34.22	21.96
Other Operating Income	0.00	0.00	0.00	0.00	0.00	0.00
Other Income	0.98	0.16	1.87	0.26	1.93	0.64
Total Income	29.42	40.84	43.82	42.50	36.15	22.60
Total Expenditure	30.52	36.67	35.65	34.62	31.18	19.42
PBIDT	-1.10	4.16	8.16	7.88	4.97	3.18
Interest	0.58	0.44	0.60	0.70	0.58	0.45
PBDT	-1.67	3.73	7.56	7.18	4.39	2.73
Depreciation	1.27	1.24	1.21	1.53	1.40	1.12
Tax	0.00	0.00	0.00	0.28	0.00	0.00
Deferred Tax	0.00	0.00	0.00	0.00	0.00	0.00
Reported Profit After Tax	-2.94	2.48	6.35	5.37	3.00	1.61
Extra-ordinary Items	0.00	0.00	0.00	0.00	0.00	0.00
Adjusted Profit After Extra-ordinary item	-2.94	2.48	6.35	5.37	3.00	1.61

EPS (Unit Curr.)	-1.24	1.05	2.68	2.27	1.26	0.68
EPS (Adj) (Unit Curr.)	-1.24	1.05	2.68	2.27	1.26	0.68
Calculated EPS (Unit Curr.)	-1.24	1.05	2.68	2.27	1.27	0.68
Calculated EPS (Adj) (Unit Curr.)	-1.24	1.05	2.68	2.27	1.27	0.68
Calculated EPS (Ann.) (Unit Curr.)	-4.98	4.20	10.74	9.08	5.06	2.72
Calculated EPS (Adj) (Ann.) (Unit Curr.)	-4.98	4.20	10.74	9.08	5.06	2.72
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Dividend (%)	0.00	0.00	0.00	0.00	0.00	0.00
Equity	23.66	23.66	23.66	23.66	23.66	23.66
Reserve & Surplus	0.00	0.00	0.00	0.00	0.00	0.00
Face Value	10.00	10.00	10.00	10.00	10.00	10.00

Public Shareholding (No. Of Shares)	0.00	0.00	0.00	0.00	0.00	0.00
Public Shareholding (% in Equity)	0.00	0.00	0.00	0.00	0.00	0.00

Pledged/Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

Non Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

PBIDTM(%)	-3.87	10.23	19.45	18.66	14.52	14.48
PBDTM(%)	-5.87	9.17	18.02	17.00	12.83	12.43
PATM(%)	-10.34	6.10	15.14	12.71	8.77	7.33

Balance Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18
SOURCES OF FUNDS :
Share Capital	23.66	23.66	23.66	2.37	23.66	23.66
Reserves Total	49.80	38.31	33.11	-6.78	-2.86	16.87
Equity Share Warrants	0.00	0.00	0.00	0.00	0.00	0.00
Equity Application Money	0.00	0.00	0.00	55.36	0.00	0.00
Total Shareholders Funds	73.46	61.97	56.77	50.95	20.80	40.53
Secured Loans	21.42	9.04	2.50	0.00	44.10	44.37
Unsecured Loans	1.51	2.02	12.79	3.02	2.13	2.17
Total Debt	22.93	11.06	15.29	3.02	46.23	46.54
Total Liabilities	96.39	73.03	72.06	53.97	67.03	87.07
APPLICATION OF FUNDS :
Gross Block	94.66	87.94	79.57	74.09	72.87	72.54
Less : Accumulated Depreciation	54.43	49.09	43.60	39.12	35.86	32.60
Less:Impairment of Assets	0.00	0.00	0.00	0.00	0.00	0.00
Net Block	40.23	38.85	35.97	34.97	37.01	39.94
Lease Adjustment	0.00	0.00	0.00	0.00	0.00	0.00
Capital Work in Progress	1.50	0.00	0.83	0.21	0.00	0.00
Producing Properties	0.00	0.00	0.00	0.00	0.00	0.00
Investments	0.00	0.00	0.00	0.00	1.43	1.43
Current Assets, Loans & Advances	0.00	0.00	0.00	0.00	0.00	0.00
Inventories	22.22	20.28	15.44	11.41	9.28	10.67
Sundry Debtors	41.15	14.78	9.56	6.03	24.83	24.28
Cash and Bank	7.81	0.17	1.80	8.48	2.70	2.70
Loans and Advances	16.13	15.65	22.86	9.95	11.42	10.63
Total Current Assets	87.31	50.88	49.67	35.88	48.24	48.29
Less : Current Liabilities and Provisions	0.00	0.00	0.00	0.00	0.00	0.00
Current Liabilities	31.36	14.71	14.31	17.10	47.41	35.74
Provisions	0.63	1.56	0.00	0.00	0.00	0.00
Total Current Liabilities	31.99	16.27	14.31	17.10	47.41	35.74
Net Current Assets	55.33	34.61	35.36	18.78	0.83	12.55
Miscellaneous Expenses not written off	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Assets	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Liability	0.00	0.00	0.00	0.00	6.18	4.68
Net Deferred Tax	0.00	0.00	0.00	0.00	-6.18	-4.68
Total Assets	97.06	73.46	72.16	53.96	33.10	49.24
Contingent Liabilities	10.93	6.17	2.00	5.00	0.03	0.50

Column	Mar 20	Mar 19	Mar 18	Mar 17	Mar 16	Mar 15
SOURCES OF FUNDS :
Share Capital	2.37	23.66	23.66	18.66	18.66	18.66
Reserves Total	-6.61	-4.60	14.27	20.01	39.10	53.12
Equity Share Warrants	0.00	0.00	0.00	4.00	0.00	0.00
Equity Application Money	55.36	0.00	0.00	0.00	0.00	0.00
Total Shareholders Funds	51.12	19.06	37.93	42.67	57.76	71.78
Minority Interest	0.08	-0.21	-0.73	-0.55	0.00	0.93
Secured Loans	0.00	44.10	44.37	80.14	80.48	68.65
Unsecured Loans	3.02	2.13	2.17	2.24	0.00	0.00
Total Debt	3.02	46.23	46.54	82.38	80.48	68.65
Policy Holders Fund	0.00	0.00	0.00	0.00	0.00	0.00
Other Liabilities	0.00	0.63	12.95	12.79	0.92	0.39
Total Liabilities	54.22	65.71	96.69	137.29	139.16	141.75
APPLICATION OF FUNDS :
Gross Block	74.13	72.91	79.77	79.65	79.67	77.36
Less: Accumulated Depreciation	39.12	35.86	34.88	31.04	27.06	22.80
Less: Impairment of Assets	0.00	0.00	0.00	0.00	0.00	0.00
Net Block	35.01	37.05	44.89	48.61	52.61	54.56
Lease Adjustment	0.00	0.00	0.00	0.00	0.00	0.00
Capital Work in Progress	0.21	0.00	0.00	0.00	0.00	0.00
Producing Properties	0.00	0.00	0.00	0.00	0.00	0.00
Investments	0.00	0.00	0.00	16.90	16.90	16.90
Current Assets, Loans & Advances	0.00	0.00	0.00	0.00	0.00	0.00
Inventories	11.41	9.28	10.67	16.74	16.38	16.12
Sundry Debtors	6.03	24.83	24.28	53.78	67.96	88.69
Cash and Bank	8.48	2.71	2.95	2.66	2.71	2.77
Loans and Advances	10.17	11.64	10.83	4.01	35.42	19.51
Total Current Assets	36.10	48.47	48.74	77.18	122.48	127.09
Less : Current Liabilities and Provisions	0.00	0.00	0.00	0.00	0.00	0.00
Current Liabilities	17.10	47.58	36.56	38.10	49.74	54.07
Provisions	0.00	0.00	0.00	0.00	0.00	0.00
Total Current Liabilities	17.10	47.58	36.56	38.10	49.74	54.07
Net Current Assets	19.00	0.89	12.18	39.09	72.74	73.02
Miscellaneous Expenses not written off	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Assets	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Liability	0.00	6.18	5.11	2.92	3.82	4.00
Net Deferred Tax	0.00	-6.18	-5.11	-2.92	-3.82	-4.00
Other Assets	0.00	33.95	44.73	35.61	0.72	1.28
Total Assets
Contingent Liabilities	0.03	0.03	0.00	0.29	1.64	11.56

Cash Flow

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

PARTICULARS	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019
Cash and Cash Equivalents at Beginning of the year	0.17	1.80	8.48	2.70	2.70
Net Cash from Operating Activities	4.95	9.73	-13.61	-34.27	-1.10
Net Cash Used In Investing Activities	-7.49	-6.54	-5.35	32.78	3.53
Net Cash Used In Financing Activities	10.18	-4.81	12.28	7.27	-2.44
Net Inc./Dec In Cash And Cash Equivalents	7.64	-1.63	-6.68	5.78	0.00
Cash And Cash Equivalents At End Of The Year	7.81	0.17	1.80	8.48	2.70

Share Holding

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Promoter Shareholding

88.30%

FII Shareholding

0.00%

DII Shareholding

0.00%

Public Shareholding

11.70%

**Promoter pledged shareholding 88.30%

About Bafna Pharmaceuticals Ltd

Bafna Pharmaceuticals Ltd is in the Pharmaceuticals sector, having a market capitalization of Rs. 207.73 crores. It has reported a sales of Rs. 28.44 crores and a net profit of Rs. -2.94 crores for the quarter ended December 2018. The company management includes Shanmugam Hemalatha, Babulal Kamlesh Kumar,Shanmugam Hemalatha,Akilapriya Chandrashekar Raju,Palamadai Krishnan Sundaresan,Ravichandran Chitra,Vishnu Vasudeva Kuppa,Upendar Mekala Reddy,Krishna Yeachuri,Vinayak Dinesh Dendukuri,Upendar Mekala Reddy,Krishna Yeachuri (Bafna Pharmaceuticals Ltd) among others.

Chairman

Shanmugam Hemalatha

Registered office

Bafna Towers New No 68,Old No 299 Thambu Chetty St,Chennai,Tamil Nadu,600001

FAX :91-44-25231264/42677599

Background

Incorporation Year1995

Face Value₹10

Market Lot1

How to buy Bafna Pharma. shares on nse?

To buy Bafna Pharma. shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified

What is the Bafna Pharma. share price today?

The Bafna Pharma. shares price on nse is Rs.87.81 today.

What is the market cap of Bafna Pharma. shares on BSE ?

The company has a market capitalization of Rs.207.73Cr

What is the PE & PB ratio of Bafna Pharma. shares ?

PE is 18.45 and PB is 2.52

What is the 52 Week High and Low of Bafna Pharma. shares?

Bafna Pharma. stock price high: Rs.125.55 Bafna Pharma. stock price low: Rs.76.5